PreciControl CMV IgG - Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, control
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
26-05-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Roche Diagnostics Australia Pty Limited
Class:
Class 4
Manufactured by:
Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany
Therapeutic area:
49717 - Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, control
Therapeutic indications:
Ready to use control serum based on human serum for use on the Elecsys and cobas e immunoassay analyzers Ready to use serum for the quality control of the Elecsys CMV IgG Immunoassay.
Authorization status:
A
Authorization date:
2018-11-02
